Apollo to respond to CSE
Lanka Hospitals Company Limited (LHCL) will respond
to the Colombo Stock Exchange (CSE) this week clarifying the details
of the incentive package offered by the Board of Investment (BOI)
to the Apollo hospital.
LHCL Vice Chairman R. Navaratnam told The Sunday
Times FT that the company received the letter on Thursday and will
be writing to the CSE in the next few days after consulting with
the other directors of the company.
The CSE requested information on whether BOI had
granted their incentives to a ‘particular set of investors’
or to the company itself.
CSE said it considers this as material information.
“What they want to find out is whether the
BOI incentives were given to Dr. Reddy and family or to the Apollo
Hospitals.
None of this has been stated in the initial public
offering (IPO) prospects,” an industry source said.
Navaratnam said that the holding company of Apollo
is LHCL and that the initial prospectus for the initial public offering
(IPO) speaks only about Apollo Hospitals.
“The prospectus speaks about Apollo Hospitals
throughout and not LHCL,” he said. SLIC is currently the largest
shareholder of the company, while Apollo Hospitals Enterprises of
India owns only 33 percent, with a Director of the Company also
owning three percent.
The third largest shareholder is the state owned,
but listed Property Development (PDL) with a three percent stake.
|